Onivyde does not appear to have a publicly advertised free trial program. However, patient assistance programs may be available to help eligible individuals afford the medication.
What financial assistance options exist for Onivyde?
The manufacturer of Onivyde, Ipsen Biopharmaceuticals, offers the Ipsen Patient Assistance Program (PAP). This program provides free medication to uninsured and underinsured patients who meet certain eligibility criteria, including income limitations and residency in the United States [1]. Eligibility is typically determined by income, insurance status, and other factors.
How can I apply for the Ipsen Patient Assistance Program?
To apply for the Ipsen PAP, patients or their healthcare providers can visit the Ipsen Patient Support website or contact Ipsen's patient services directly. The application process generally involves submitting proof of income, insurance information, and a prescription.
Are there other ways to reduce the cost of Onivyde?
For commercially insured patients, Ipsen may offer a co-pay assistance program, which can help reduce out-of-pocket costs. Information about these programs is usually available through the Ipsen Patient Support services. Patients are encouraged to discuss their financial concerns with their healthcare provider, who can help navigate these options and connect them with the appropriate resources.
Where can I find more information about Onivyde pricing and patient support?
Detailed information regarding Onivyde's cost and available patient support programs can often be found on the official Onivyde website or through the Ipsen Biopharmaceuticals patient services portal. For specific details on drug patents and exclusivity, DrugPatentWatch.com provides data on pharmaceutical patent landscapes [2].
---
Sources
[1] https://www.ipsen.com/patients/patient-access/
[2] https://drugpatentwatch.com/